At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 10 enrolled
Drug / intervention
Prednisonedrug
Likely dose
Prednisone 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Glucocorticoid Effects in Patients With DM Type 2
In Brief
A Early Phase 1 clinical trial evaluating Prednisone for Diabetes and Hyperglycemia Steroid-induced. Completed, enrolled 10 participants.
Detailed Summary
Participants will receive prednisone 40 mg for 3 days. 75 g oral glucose tolerance test (OGTT), insulin and C-peptide will be measured on day 1 (before prednisone) and day 3 (after prednisone). Also capillary glucose values will be obtained during and after the period of prednisone intake.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Hyperglycemia Steroid-induced
Countries--
Collaborators--
Timeline
Early Ph 1CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
Primary CompletionApr 2017
Study CompletionJul 2017
First PostedSep 2018
TodayJul 2026
First PostedSep 7, 2018
Enrollment StartJun 3, 2016
Primary CompletionApr 1, 2017
Study CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.8 years ago
Interventions
Prednisonedrug
40 mg po q day of Prednisone for 3 days